Overview
Welcome to Investor Relations
Trusted by over 2,500 companies to safeguard their R&D investments, innoscripta delivers all-in-one software that brings transparency to research and development. Our strategy centers on innovation, sustainability, and growth, expanding our market presence while creating long-term value for shareholders.
Max Hunger
Head of Investor Relations
~€1.9tn
Gross domestic R&D spend in OECD (2023)(1)
Leading
R&D tax credit software(2)
>2.500
Signed clients(3)
2.9years
Average contract duration (most of which auto-renewed)
<2%
Churn rate(4)
€63.6m
EBIT (2025A)(5)
90.5%
EBIT CAGR (2022A-2025A)(5)
>60%
EBIT margin (2025A)(5)
31%
of non-SME companies receiving positive BSFZ certificate in 2025 were innoscripta customers(6)
Note(s): (1) Source: OECD; (2) Based on Management Calculations; (3) As of 31 December 2025; (4) Refers to the 2022-2025 period. Customer churn rate refers to number of customers contracts terminated divided by the sum of the existing and newly signed customer contracts in the respective year; (5) EBIT 2024A and 2025A are adjusted for IPO costs. (6) Based on official BSFZ statistics for 2025 published by the German Federal Ministry for Research, Technology and Space (BMFTR) and the Company's internal customer data and management analysis
Awarded as one of the fastest-growing companies in Europe
FT 1000 Growth Champions
What makes us special?
A fully integrated approach to R&D management that delivers measurable results across planning, funding, and compliance.
Integrated R&D platform
Project planning, funding applications, and compliance management combined in one user-friendly system.
Funding success rate
Advanced AI insights and optimizations that consistently outperform industry standards.
Customer growth
Our customer base multiplied 30 times in just four years, proving real-world impact.
Ready to explore investment opportunities?
Max Hunger
Head of Investor Relations
